New cancer clinical trial: Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

Published on: January 30, 2019 at 12:00PM
Conditions:   Prostatic Neoplasms;   Prostatic Neoplasms, Castration-Resistant
Intervention:   Drug: Ga-68 PSMA-HBED-CC PET
Sponsor:   Michael Graham
Not yet recruiting
http://bit.ly/2CXEkhk